Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatitis B Virus Reactivation in Asian Patients Treated With Rituximab-containing Treatment

NCT01311232 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01311232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01311232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatitis B Virus Reactivation in Asian Patients Treated With Rituximab-containing Treatment
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
November 1, 2010
Completion date
December 1, 2013
Enrollment
600 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

patients treated with rituximab-chop or rituximab-cvp, patients with diffuse large b-cell lymphoma or follicular lymphoma